Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|May 9, 2008
The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitisHiroshi Fujishima, Kazumi Fukagawa, Mari Tanaka, et al.Ophthalmology|December 27, 2016
Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular DiseasesDai Miyazaki, Atsuki Fukushima, Yuichi Ohashi, et al.Allergology International : Official Journal of the Japanese Society of Allergology|February 25, 2012
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspensionNobuyuki Ebihara, Yuichi Ohashi, Hiroshi Fujishima, et al.Current Eye Research|April 6, 2019
Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic DermatitisJun Shoji, Yuichi Ohashi, Atsuki Fukushima, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 16, 2009
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitisNobuyuki Ebihara, Yuichi Ohashi, Eiichi Uchio, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 24, 2010
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitisYuichi Ohashi, Nobuyuki Ebihara, Hiroshi Fujishima, et al.The British Journal of Ophthalmology|April 4, 2014
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvementAtsuki Fukushima, Yuichi Ohashi, Nobuyuki Ebihara, et al.Japanese Journal of Ophthalmology|October 7, 2020
Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseasesDai Miyazaki, Daisuke Shimizu, Atsuki Fukushima, et al.Nippon Ganka Gakkai Zasshi|July 9, 2011
[A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, et al.Allergology International : Official Journal of the Japanese Society of Allergology|November 19, 2020
Japanese guidelines for allergic conjunctival diseases 2020Dai Miyazaki, Etsuko Takamura, Eiichi Uchio, et al.Pageof 4